Prakiraan pendapatan perusahaan: Heron (HRTX)

Heron Therapeutics, Inc. (HRTX) - logo korporat

Heron Therapeutics (HRTX) attracts top specialists and a commercial workforce by relying on ethical principles and competitive compensation. The firm's estimated sales volume demonstrates market dynamics, where the 0.15 mark reflects the asset's current state. The company is implementing extended-release pain management systems to reduce opioid dependence, while its mature portfolio of chemotherapy-induced nausea drugs drives commercial revenue growth.

Volume dodolan sing dikarepake perusahaan: Heron Therapeutics (HRTX) kanggo 04.07.2022 - 18.11.2026

Ringkesan rincian data analitis Heron Therapeutics, Inc. (HRTX)

- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
Pambiji fundamental:Heron Therapeutics, Inc. HRTX
Sampel barang herontx.com

By diversifying the supply of drugs for oncology clinics and surgery, Heron Therapeutics (HRTX) aims to expand its market reach, which is reflected in the value of 0.15. The stagnation of the company's target sales volumes against a backdrop of industry growth signals a loss of market share and hidden risks, turning the lack of momentum into an indicator of declining investment attractiveness and the probability of capital freezing.

Pesaing wigati

Prakiraan pendapatan perusahaan Incyte Pharma (INCY)|Prakiraan pendapatan perusahaan HCM (Hutchison MediPharma)|Prakiraan pendapatan perusahaan Nuvation Pharma NUVB|Day One Biopharmaceuticals Inc - Prakiraan pendapatan perusahaan|MNPR - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Inhibrx Biosciences|IMAB: Prakiraan volume dodolan|Prakiraan dodolan perusahaan Fennec Pharmaceuticals Inc FENC|Volume dodolan mangsa ngarep perusahaan NVCT|Volume dodolan sing dikarepake perusahaan Coherus Biosciences CHRS|Volume dodolan mangsa ngarep perusahaan CRBP (Corbus Pharmaceuticals)|CRDF (Cardiff Oncology Corp) - Pendapatan mangsa ngarep perusahaan|BeyondSpring Inc. - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan BCAB (BioAtla Corp)|Lixte Biotechnology Holdings - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan CTXR (citiuspharma.com)|CLRB: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan biolinerx.com (BLRX)|Prakiraan pendapatan perusahaan Can-Fite BioPharma Ltd.|APRE: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan KZIA|Prakiraan volume dodolan Silexion Therapeutics Corp. (SLXN)|Prakiraan pendapatan perusahaan NuCana PLC NCNA|CMRX (Chimerix) - Pendapatan sing dikarepake perusahaan|CYCC: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan g1therapeutics.com|Kronos Bio Inc (KRON) - Prakiraan pendapatan perusahaan|Kintara (KTRA) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Oncternal Therapeutics, Inc.|Volume dodolan sing dikarepake perusahaan portagebiotech.com PRTG